Oseltamivir (Tamiflu) unsafe in infants under 1 year old

February 2004
CMAJ: Canadian Medical Association Journal;2/3/2004, Vol. 170 Issue 3, p336
Academic Journal
Reports on the warning by the U.S. Food and Drug Administration regarding the use of oseltamivir for treatment of influenza in infants under 1 year old. Mechanism of action of the drug; Details of the studies involving juvenile rats which showed potential toxicity of oseltamivir; Ways to prevent the disease.


Related Articles

  • FDA clears first test designed to detect/identify 12 respiratory viruses from single sample.  // Healthcare Purchasing News;Feb2008, Vol. 32 Issue 2, p8 

    The article reports that the xTAG Respiratory Viral Panel, a test that will simultaneously detect and identify 12 specific respiratory viruses, has been cleared by the U.S. Food and Drug Administration (FDA). The new test, manufactured by Luminex Molecular Diagnostics, is the first one for the...

  • First test to detect and identify 12 respiratory viruses.  // WHO Drug Information;2008, Vol. 22 Issue 1, p21 

    The article reports on the approval of the xTAG Respiratory Viral Panel test in detecting and identifying respiratory viruses by the Food and Drug Administration (FDA) in the U.S. The test has the capability of differentiating influenza A subtypes H1 and H3, and detecting human metapneumovirus...

  • Advisory Committee on Immunization Practices Recommendations/Clinical Management. Reisinger, Keith S. // Contemporary Pediatrics;Feb2008 Supplement, Vol. 25, p9 

    This article presents information on influenza vaccines. These vaccines are trivalent, and each year, both influenza vaccine types are reformulated based on the viral strains that are predicted to circulate in the upcoming influenza season. Trivalent inactivated influenza vaccine (TIV) is grown...

  • FDA Approves New Version of MedImmune Flu Vaccine. Kaye, Donald // Clinical Infectious Diseases;3/1/2007, Vol. 44 Issue 5, piii 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved new version of Medimmune Inc.'s nasal spray flu vaccine FluMist. The new one does not require to be kept frozen and can reportedly be easily refrigerated. The FDA has approved the drug to help prevent influenza in...

  • Molecular Laboratory Tests for the Diagnosis of Respiratory Tract Infection Due to Staphylococcus aureus. Peterson, Lance R. // Clinical Infectious Diseases;2011, Vol. 52 Issue suppl_4, pS361 

    When Staphylococcus aureus is the cause of ventilator-associated pneumonia or a bacterial infection following influenza, the infections are devastating if not treated promptly. Disease due to methicillin-resistant S. aureus (MRSA) continues to be of concern throughout most of the United States....

  • FDA Authorizes Emergency Use of Tamiflu and Relenza to Treat Swine Flu.  // BioPharm International;Jun2009, Vol. 22 Issue 6, p12 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) on the use of Relenza and Tamiflu to treat swine flu. The FDA has given authority on the use of the ontiviral drugs beyond their sanctioned indications in response to the outbreak of swine flu. In addition,...

  • FDA Researchers Contribute Insights into Avian Flu Virus.  // BioPharm International;Jun2009, Vol. 22 Issue 6, p12 

    The article presents a study, conducted by U.S. Food and Drug Administration (FDA) researchers, rerlated to H5N1 avian influenza virus. Here, the researchers adapted a technique using genetically modified viruses to create fragments representing all of the proteins found in the bird flu virus....

  • Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate-a validated assay for the clinic. Hooff, Gero P.; Meesters, Roland J. W.; van Kampen, Jeroen J. A.; van Huizen, Nick A.; Koch, Birgit; Al Hadithy, Asmar F. Y.; van Gelder, Teun; Osterhaus, Albert D. M. E.; Gruters, Rob A.; Luider, Theo M. // Analytical & Bioanalytical Chemistry;Oct2011, Vol. 400 Issue 10, p3473 

    The neuraminidase inhibitor oseltamivir (Tamiflu®) is currently the first-line therapy for patients with influenza virus infection. Common analysis of the prodrug and its active metabolite oseltamivircarboxylate is determined via extraction from plasma. Compared with these assays, dried blood...

  • Pandemic Preparedness Pacing Up. Baylor, Norman W. // BioPharm International;Aug2007 Supplement, Vol. 20, p6 

    The article reports on the development of a new criteria vaccine evaluation against pandemic influenza strains for licensure by the U.S. Food and Drug Administration and National Regulatory Authorities (NRAs). New technologies such as cell culture-based and reverse genetics have been advancing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics